Clinical Development Programs

 

By working with established Active Pharmaceutical Ingredients (APIs), SST utilizes the FDA 505(b)(2) regulatory pathway to accelerate development and commercialization of both over-the-counter (OTC) and prescription drug product candidates. SST has three programs currently in active development. All formulas are patented.